You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 19, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Madison M Driskill1, Ian A Coates1, Paul J Hurst2
1Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.
This study developed a thermostable self-amplifying RNA (saRNA) vaccine using lyophilization, reducing cold-chain dependence. The saRNA vaccine, delivered via microfluidic microarray patches, induced robust immune responses, improving vaccine accessibility.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: